Page last updated: 2024-09-03

c 1311 and Neutropenia

c 1311 has been researched along with Neutropenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourbouloux, E; Campone, M; Capizzi, R; Drouin, M; Fumoleau, P; Grieshaber, C; Isambert, N; Loadman, P; Major, A; Yin, W1

Trials

1 trial(s) available for c 1311 and Neutropenia

ArticleYear
Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours.
    European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:4

    Topics: Administration, Oral; Adult; Aged; Aminoacridines; Antineoplastic Agents; Biological Availability; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Treatment Outcome

2010